These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Menopausal flushes: effect of pituitary gonadotropin desensitization by a potent luteinizing hormone- releasing factor agonist. Casper RF; Yen SS J Clin Endocrinol Metab; 1981 Nov; 53(5):1056-8. PubMed ID: 6793613 [TBL] [Abstract][Full Text] [Related]
25. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause. Chakravarti S; Collins WP; Thom MH; Studd JW Br Med J; 1979 Apr; 1(6169):983-5. PubMed ID: 219937 [TBL] [Abstract][Full Text] [Related]
26. Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach. Lemay A; Faure N J Clin Endocrinol Metab; 1986 Dec; 63(6):1379-85. PubMed ID: 2946711 [TBL] [Abstract][Full Text] [Related]
27. Growth hormone secretion in idiopathic precocious puberty: effect of medroxyprogesterone. Kaplan S; Frasier SD; Costin G J Pediatr; 1969 Jul; 75(1):133-8. PubMed ID: 5790396 [TBL] [Abstract][Full Text] [Related]
28. Pulsatile plasma profiles of FSH and LH before and during medroxyprogesterone acetate treatment in the bitch. Beijerink NJ; Bhatti SF; Okkens AC; Dieleman SJ; Duchateau L; Kooistra HS Theriogenology; 2008 Jul; 70(2):179-85. PubMed ID: 18455225 [TBL] [Abstract][Full Text] [Related]
29. Use of medroxyprogesterone acetate to prevent menopausal symptoms. Bullock JL; Massey FM; Gambrell RD Obstet Gynecol; 1975 Aug; 46(2):165-8. PubMed ID: 1153148 [TBL] [Abstract][Full Text] [Related]
30. Menopause, medroxyprogesterone and breathing during sleep. Block AJ; Wynne JW; Boysen PG; Lindsey S; Martin C; Cantor B Am J Med; 1981 Mar; 70(3):506-10. PubMed ID: 7211892 [TBL] [Abstract][Full Text] [Related]
31. Possible role of hormones in treatment of metastatic testicular teratomas: tumour regression with medroxyprogesterone acetate. Bloom HJ; Hendry WF Br Med J; 1973 Sep; 3(5880):563-7. PubMed ID: 4726928 [TBL] [Abstract][Full Text] [Related]
33. Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. World Health Organization, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulation. Said S; Sadek W; Rocca M; Koetsawang S; Kirwat O; Piya-Anant M; Dusitsin N; Sethavanich S; Affandi B; Hadisaputra W; Kazi A; Ramos RM; d'Arcangues C; Belsey EM; Noonan E; Olayinka I; Pinol A Hum Reprod; 1996 Oct; 11 Suppl 2():1-13. PubMed ID: 8982739 [TBL] [Abstract][Full Text] [Related]
34. GnRH-test after high-dose MPA in women with post-menopausal LH-preferential release. Marchesoni D; Mozzanega B; Maggino T Clin Exp Obstet Gynecol; 1983; 10(2-3):95-101. PubMed ID: 6313259 [TBL] [Abstract][Full Text] [Related]
35. Effect of naloxone on menopausal flushes, skin temperature, and luteinizing hormone secretion. Tulandi T; Kinch RA; Guyda H; Maiolo LM; Lal S Am J Obstet Gynecol; 1985 Jan; 151(2):277-80. PubMed ID: 2982266 [TBL] [Abstract][Full Text] [Related]
36. A comparison of the central effects of different progestins used in hormone replacement therapy. Cagnacci A; Arangino S; Baldassari F; Alessandrini C; Landi S; Volpe A Maturitas; 2004 Aug; 48(4):456-62. PubMed ID: 15283939 [TBL] [Abstract][Full Text] [Related]
37. A preliminary evaluation of the effect of lofexidine on vasomotor flushes in post-menopausal women. Jones KP; Ravnikar V; Schiff I Maturitas; 1985 Jul; 7(2):135-9. PubMed ID: 4033447 [TBL] [Abstract][Full Text] [Related]
38. The effect of medroxyprogesterone acetate on the pituitary-adrenal axis. Hellman L; Yoshida K; Zumoff B; Levin J; Kream J; Fukushima DK J Clin Endocrinol Metab; 1976 May; 42(5):912-7. PubMed ID: 178684 [TBL] [Abstract][Full Text] [Related]
39. Effect of intravenous clonidine on menopausal flushing and luteinizing hormone secretion. Tulandi T; Lal S; Kinch RA Br J Obstet Gynaecol; 1983 Sep; 90(9):854-7. PubMed ID: 6351899 [TBL] [Abstract][Full Text] [Related]
40. Prolonged endocrine responses to medroxyprogesterone in postmenopausal women with respiratory insufficiency. Saaresranta T; Irjala K; Polo-Kantola P; Helenius H; Polo O Obstet Gynecol; 2000 Aug; 96(2):243-9. PubMed ID: 10908771 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]